Payers are planning for an increasing number of gene therapies being approved by developing new coverage programs
Diplomat found that competing successfully with large specialty pharmacies owned by Cigna/ESI, CVS Health/Caremark and UnitedHealth/OptumRx has been more difficult than projected
Haven Healthcare is following the “disruption” model developed by Amazon
Amazon Alexa announced that it now is capable of transmitting and receiving protected health information. Its new HIPAA-compliant status means that operators and residents alike may find more reasons to use the device. The company has been working with six organizations to develop “skills” to manage a variety of healthcare needs at home simply using […]
Anthem-Cigna Merger Affected by Blues Plans The large employer market is playing the lead role in the Anthem-Cigna merger lawsuit. The Department of Justice stated that the health insurance merger would create major concentration when selling health plans and services to large employers. (Health Affairs Blog, December 28, 2016) One interesting aspect of the Anthem-Cigna […]
Increasing Demand for Drug Based Outcomes – Outcome-based contracts are a relatively new and growing contracting methodology focused on shifting reimbursement from volume to value. The contracts are between a health plan and manufacturer where reimbursement is dependent on pre-defined outcome metrics focused on improving patient responses/health. Currently, the relationship between the pharmaceutical manufacturer, the […]
The Anthem Cigna merger: 10 things to Know – Published July 24, 2015 By Tracey Walker, Managed Healthcare Executive Anthem’s acquisition of Cigna is being called the first “merger of titans” by industry watchers. The forces of consolidation are well under way and the merger was not totally unexpected—all of insurance is going through similar […]